Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and safety study of TPN171H tablets in patients with renal insufficiency and healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Pulmonary Arterial Hypertension

Drugs mentioned

• TPN171H

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Pulmonary Arterial Hypertension, Erectile Dysfunction | Phase 1 | Status: COMPLETED